Introduction of Deczuba 50 mg Injection

• ​Deczuba 50 mg Injection is an anti-cancer medication used for the treatment of myelodysplastic syndrome. A myelodysplastic syndrome is a group of diseases in which the bone marrow doesn’t produce enough healthy blood cells. Instead, it makes too many immature cells, called blasts. It is also used to treat blood cancer called acute myeloid leukaemia (AML). Deczuba 50 mg Injection works by killing those abnormal cells which are present in the bone marrow and helps to produce normal blood cells.
  
  ​​Deczuba 50 mg Injection may cause some common adverse effects including nausea, vomiting, diarrhoea, headache, fever and lung infection. These side effects are usually not serious but tell your doctor if they bother you or do not go away. Deczuba 50 mg Injection may affect your immune system. You may get infections more easily, even serious or fatal diseases. Do not take this Deczuba 50 mg Injection If you experience any symptoms like fever, chills, cough, mouth sores, or unusual bleeding or bruising. Please consult your doctor immediately.
  
  ​Before taking Deczuba 50 mg Injection, inform your doctor if you have any pre-existing disease such as liver or kidney disease, low white blood cell count or any other medical complications you have and if you are using any prescription medicines and non-prescription medicines, herbal, vitamins, etc. Many other medicines will interact with this medicine, so please make sure inform to the doctor. Deczuba 50 mg Injection is not recommended for use in pregnant and breastfeeding women, it may cause birth defects. Deczuba 50 mg Injection may affect fertility. However, it is important to use birth control to prevent pregnancy because Deczuba 50 mg Injection can harm an unborn baby.
  
  ​​Deczuba 50 mg Injection is administered by a doctor or nurse at a hospital or clinical setting. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it strictly as your doctor has advised. Taking it the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol as it may increase your risk of liver damage. Do not self-administered this Deczuba 50 mg Injection.​
  

Uses of Deczuba 50 mg Injection

• ​Deczuba 50 mg Injection is an anti-cancer medication used for the treatment of myelodysplastic syndrome (Myelodysplastic syndrome (MDS) is a group of blood disorders in which the bone marrow, which is responsible for producing blood cells, produces abnormal cells. These abnormal cells can be immature and not function properly, leading to a decrease in the number of healthy blood cells in the body. The symptoms may include fatigue, weakness, shortness of breath, fever, and easy bruising or bleeding.
  
  ​Acute Myeloid Leukemia (Blood Cancer): Deczuba 50 mg Injection is used in the treatment of acute myeloid leukaemia (blood cancer) is a type of cancer that affects the white blood cells, specifically, the myeloid cells, which are responsible for producing red blood cells, platelets, and other white blood cells. Symptoms can include fatigue, weakness, shortness of breath, fever, night sweats, easy bruising or bleeding, frequent infections, and swollen lymph nodes.​
  

Benefits of Deczuba 50 mg Injection

• ​Myelodysplastic syndrome: Deczuba 50 mg Injection is used to treat myelodysplastic syndrome, a group of conditions in which the bone marrow produces blood cells that are abnormal in structure and function, and does not produce enough healthy blood cells. Deczuba 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.

  Acute myeloid leukaemia (AML): Deczuba 50 mg Injection is used to treat acute myeloid leukaemia is a type of blood cancer that affects the white blood cells, specifically, the myeloid cells, which are responsible for producing red blood cells, platelets, and other white blood cells. In AML, the myeloid cells become abnormal and do not function properly, leading to a decrease in healthy blood cells and an increase in abnormal cells. Deczuba 50 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
  

Side Effects of Deczuba 50 mg Injection

• ​​Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.​

Most Common Side Effects of Deczuba 50 mg Injection

• • Insomnia
  • Nausea
  • Constipation
  • Diarrhoea
  • Vomiting
  • Stomach pain
  • Painful sores in mouth or tongue or lips
  • Indigestion
  • Heartburn
  • Rashes
  • Itching
  • Hair loss
  • Skin discolouration
  • Chest discomfort
  • Muscle pain
  • Joint pain
  • Swelling over extremities
  • Pain or swelling or redness over the injection site
  • Weakness
  • Confusion
  • Headache
  • Dizziness
  • Extreme weakness

Common Side Effects of Deczuba 50 mg Injection

• • Bruising
  • Unusual bleeding
  • Facial swelling
  • Respiratory distress, breathing difficulty, rapid breathing, tachypnoea
  • Sore throat
  • High
  • grade fever with chills
  • Other signs of infection

How to Use Deczuba 50 mg Injection?

• ​​Deczuba 50 mg Injection is available in powder form which must be diluted and administered into the vein (IV) slowly as directed by your doctor. Deczuba 50 mg Injection is administered by a doctor or nurse at a hospital or clinical setting. The dosage and frequency and interval (duration of infusion) depend upon your medical condition, body size, lab test results and response towards the treatment given. Don't administer this drug by yourself, it must be administered under medical supervision by health care professionals only. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol as it may increase your risk of liver damage. Do not self-administered this Deczuba 50 mg.​
  

How Deczuba 50 mg Injection Works?

• ​​Deczuba 50 mg Injection is a medication used to treat certain types of blood cancers, including myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML). Deczuba 50 mg Injection works by interfering with DNA methylation, a chemical modification that occurs in the DNA molecule. It is incorporated into the DNA molecule during DNA replication, preventing the proper DNA methylation. This interference with DNA methylation can lead to the re-expression of tumour suppressor genes, which can help slow or stop cancer cell growth.​
  

Safety Advices Deczuba 50 mg Injection

Alcohol

Unsafe

It is generally not recommended to drink alcohol while taking Deczuba 50 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.

Liver

Use with Caution

Deczuba 50 mg Injection is recommended for use in patients with mild to moderate liver disease. No dose adjustment is needed in such types of patients. In case patients suffer from severe liver disease, the use of this medicine in such types of people is not recommended, It may worsen the patient's condition.

Driving

Unsafe

Deczuba 50 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Deczuba 50 mg.

Kidney

Use with Caution

Deczuba 50 mg Injection is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Deczuba 50 mg Injection is recommended. The use of Deczuba 50 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.

Breastfeeding

Unsafe

It is not recommended to breastfeed while taking Deczuba 50 mg. Deczuba 50 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Deczuba 50 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.

Pregnancy

Unsafe

Use of Deczuba 50 mg Injection may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Deczuba 50 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.